JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265532

Human ZNHIT6 (C1orf181) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

Human ZNHIT6 (C1orf181) knockout HeLa cell line available to order. Recommended control: Human wild-type HeLa cell line (ab255928).

View Alternative Names

BCD1_HUMAN, Box C/D snoRNA essential 1 homolog, Box C/D snoRNA protein 1, Chromosome 1 open reading frame 181, FLJ20729, FLJ20760, HIT type zinc finger containing protein C1orf181, Hypothetical protein LOC54680, MGC131963, NY BR 75, Serologically defined breast cancer antigen NY-BR-75, ZNHIT6, Zinc finger HIT domain-containing protein 6, Zinc finger, HIT type 6, Zinc finger, HIT type containing 6

2 Images
Sanger Sequencing - Human ZNHIT6 (C1orf181) knockout HeLa cell line (AB265532)
  • Sanger seq

Unknown

Sanger Sequencing - Human ZNHIT6 (C1orf181) knockout HeLa cell line (AB265532)

Allele-2 : 2 bp insertion in exon 1.

Sanger Sequencing - Human ZNHIT6 (C1orf181) knockout HeLa cell line (AB265532)
  • Sanger seq

Unknown

Sanger Sequencing - Human ZNHIT6 (C1orf181) knockout HeLa cell line (AB265532)

Allele-1 : 1 bp insertion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 2 bp insertion in exon 1

Disease

Adenocarcinoma

Product details

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265532-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265532 Human ZNHIT6 (C1orf181) knockout HeLa cell line", "number":"AB265532-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265532-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265532 Human ZNHIT6 (C1orf181) knockout HeLa cell line", "number":"AB265532-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ZNHIT6
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C1orf181 also known as Chromosome 1 Open Reading Frame 181 is a relatively less characterized protein which has a calculated mass of approximately 22 kDa. This protein is expressed in multiple tissues but it shows higher expression in testis and brain suggesting potential roles in these organs. C1orf181 might have specific functions related to particular cellular processes although extensive studies on its precise mechanical role remain limited.
Biological function summary

C1orf181 is associated with cellular processes that impact gene regulation and protein interactions. Although not much is known about its role evidence suggests it might be involved in protein complexes that contribute to maintaining cellular homeostasis. The structure or partners in these complexes have not been fully identified but ongoing research is aiming to unveil its interacting partners and biological implications.

Pathways

The involvement of C1orf181 may connect to regulatory networks influencing cell growth and signaling. Studies indicate potential association with the MAPK signaling pathway an important mechanism in cell proliferation and differentiation. Additionally interactions with proteins like ERK1/2 which are vital components of this pathway point towards C1orf181 influencing downstream cellular responses.

Research demonstrates some connection between C1orf181 and neurological or reproductive health issues given its expression patterns. Alterations in the function or expression of C1orf181 might associate with conditions like Parkinson's Disease or testicular dysfunctions. Researchers are examining potential interactions with proteins such as alpha-synuclein in Parkinson's to ascertain its role in disease pathology. Further studies are necessary to fully elucidate these links and their therapeutic relevance.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com